Dr. Chandra is an experienced leader in infectious diseases, with over 20 years of experience in healthcare, clinical research, and biotechnology. He is the chairman and CEO of Biogenysis Inc, a company focused on developing monoclonal antibodies, diagnostics, therapeutics, and vaccines for various viruses. Dr. Chandra and his team of scientists and engineers utilize artificial intelligence (AI) and drug discovery platforms to identify different drugs with diverse targets and applications, all aimed at positively impacting the world.

Dr. Chandra is also the COO at Enzolytics Inc. This biotechnology company specializes in discovering, acquiring, and developing pharmaceutical compounds and cutting-edge technologies for treating and diagnosing HIV/AIDS and other infectious diseases. He possesses a profound understanding of both the clinical and scientific aspects of infectious diseases and the business and management aspects of the healthcare industry. Dr. Chandra has provided consulting services and delivered speeches to companies, governments, and hospitals worldwide, leveraging his expertise and healthcare contacts in healthcare information technology, new product development, product design, and financing new ventures.

He is a prolific writer and speaker passionate about AI and its potential to transform humanity. Dr. Chandra is a highly decorated leader in healthcare and biotechnology, and his mission is to lead the charge against infectious diseases through innovation and leadership.